Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors:  

Beckman Coulter Life Sciences 

Boston Healthcare


Charles River Discovery




Silicon Biosystems   




  View All Sponsors 

Cambridge Healthtech Institute’s Fourth Annual 

Genomic Sample Prep, Biomarker Assay Development and Validation

Technologies to Enable High Sensitivity Molecular Applications

February 20-22, 2017 | Moscone North Convention Center | San Francisco, CA
Part of the 24th International Molecular Medicine Tri-Conference


Developing a highly sensitive, reproducible and robust molecular assay may be a challenge regardless of whether it is an IVD or an LDT assay. Sample preparation serves as the pivotal foundation for any advanced molecular assay development. Novel sample preparation technologies have the ability to significantly increase sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains a low concentration of analyte. Cambridge Healthtech Institute’s Fourth Annual Genomic Sample Prep, Assay Development and Validation conference is designed to bring together leading industry and academia experts in biospecimen science and molecular diagnostics to discuss major challenges and latest advances in sample preparation for advanced molecular diagnostics technologies as well as development and validation of NGS and other advanced diagnostics assays.

Who should attend: Diagnostics industry researchers and laboratory medicine professionals working on development and validation of new molecular diagnostics assays.

Topics will include, but are not limited to:

  • Critical pre-analytical issues in molecular diagnostics
  • Quantitative assessment of pre-analytic variables
  • Automated tissue sample preparation
  • Automated liquid biopsy sample preparation
  • Novel nucleic acid extraction technologies
  • Matching nucleic acid extraction method with the goal of an assay
  • IT technologies for sample management
  • NGS diagnostics assay development and validation
  • Sample prep in an era of non-invasive specimens
  • Proteomics assay development and validation for clinical applications
  • Overcoming pre-analytical issues with archived FFPE samples
  • Smaller sample preparation devices / nanotechnology applications for diagnostics
  • Target enrichment in genetically heterogeneous tumor samples
  • Microbiology sample prep and target enrichment
  • Label-free assays and sample-to-result technologies
  • Antibody validation for cancer immunotherapy companion assays

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 29, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Marina Filshtinsky, M.D.
Senior Director, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5496
E: mfilshtinsky@healthtech.com

Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z) 
Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com